Category: ARDS

  • 2nd ARDS Drug Development Summit

    Acute Respiratory Distress Syndrome (ARDS) is a growing and concerning unmet medical need with no effective therapeutic, and a serious medical burden in a world with or without COVID-19. Bringing industry together to consolidate the last 18 months of clinical and translational data; the 2nd ARDS Drug Development Summit is the only translational conference for […]

  • Unmet Needs and Emerging Trends in the Acute Respiratory Distress Syndrome Market Landscape

    Acute respiratory distress syndrome (ARDS) is a serious lung condition that is associated with a substantial rate of morbidity and mortality. It is a common cause of respiratory failure in infants and critically ill patients.  Characterized by the acute onset of noncardiogenic pulmonary oedema, hypoxaemia, ARDS makes the patients seek the need for mechanical ventilation. […]